Recursion Announces Therapeutics Advisory Board, Chaired by Joseph Miletich, MD, PhD
- Tuesday, July 13, 2021, 7:11
- Business
- Add a comment
SALT LAKE CITY, July 13, 2021 /PRNewswire/ — Recursion (NASDAQ: RXRX), a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, machine learning and engineering, today announced its formation of a Therapeutics…
About the Author
adminasapcorp has written 41775 stories on this site.